The newly generated Mecp2 Dup mouse model provides an opportunity to model the neurodevelopmental traits of patients with MDS and further explore patient predisposition to severe respiratory disease via dysregulated interferon immunity. This evidence concerns the gene MECP2 and respiratory system disorder.